A Look Ahead: Key Intellectual Property Legal Developments in 2024 - and What to Expect in 2025
From potential legal challenges to Chinese biopharma supply chains, Europe’s new Unified Patent Court (UPC), landmark decisions in life sciences, pharma’s Orange Book listings, design patent rejection...